Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELECTROLYTES NOS\POLYETHYLENE GLYCOLS: 34 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
34
Total FAERS Reports
5 (14.7%)
Deaths Reported
17
Hospitalizations
34
As Primary/Secondary Suspect
3
Life-Threatening
3
Disabilities

First Report: 2019 · Latest Report: 2019

What Are the Most Common ELECTROLYTES NOS\POLYETHYLENE GLYCOLS Side Effects?

#1 Most Reported
Drug ineffective
20 reports (58.8%)
#2 Most Reported
Nausea
16 reports (47.1%)
#3 Most Reported
Vomiting
13 reports (38.2%)

All ELECTROLYTES NOS\POLYETHYLENE GLYCOLS Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Drug ineffective 20 58.8% 2 14
Nausea 16 47.1% 3 12
Dyspnoea 13 38.2% 2 10
Vomiting 13 38.2% 3 10
Therapeutic product effect incomplete 11 32.4% 0 9
Asthma 10 29.4% 1 8
Pyrexia 10 29.4% 1 10
Wheezing 10 29.4% 1 8
Chronic obstructive pulmonary disease 9 26.5% 2 9
Lower respiratory tract infection 9 26.5% 2 9
Oedema peripheral 9 26.5% 2 9
Pulmonary embolism 9 26.5% 2 9
Macular degeneration 8 23.5% 0 2
Off label use 8 23.5% 3 7
Upper respiratory tract infection 8 23.5% 1 8
Breath sounds abnormal 7 20.6% 0 7
Cardiac murmur 7 20.6% 0 7
Eosinophilia 7 20.6% 0 7
Nasal congestion 7 20.6% 0 7
Pneumonia viral 7 20.6% 0 7

Who Reports ELECTROLYTES NOS\POLYETHYLENE GLYCOLS Side Effects? Age & Gender Data

Gender: 45.5% female, 54.5% male. Average age: 72.7 years. Most reports from: CA. View detailed demographics →

Is ELECTROLYTES NOS\POLYETHYLENE GLYCOLS Getting Safer? Reports by Year

YearReportsDeathsHosp.
2019 2 0 0

View full timeline →

What Is ELECTROLYTES NOS\POLYETHYLENE GLYCOLS Used For?

IndicationReports
Product used for unknown indication 21
Constipation 6

Official FDA Label for ELECTROLYTES NOS\POLYETHYLENE GLYCOLS

Official prescribing information from the FDA-approved drug label.